Risk factors for the development of antibody-mediated rejection in highly sensitized pediatric kidney transplant recipients-Reference-Cited by-同舟云学术

Risk factors for the development of antibody-mediated rejection in highly sensitized pediatric kidney transplant recipients

Published:2017-09-19 Issue:8 Volume:21 Page:e13042
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatr Transplantation

Author:

Kim Irene K.¹^ORCID,Choi Jua¹,Vo Ashley¹,Kang Alexis¹,Steggerda Justin¹^ORCID,Louie Sabrina¹,Haas Mark²,Mirocha James³,Cohen J. Louis¹,Pizzo Helen¹,Kamil Elaine S.¹,Jordan Stanley C.¹,Puliyanda Dechu¹

Affiliation:

1. Comprehensive Transplant Center; Cedars-Sinai Medical Center; Los Angeles CA USA

2. Department of Pathology and Laboratory Medicine; Cedars-Sinai Medical Center; Los Angeles CA USA

3. Biostatistics Core; Cedars-Sinai Medical Center; Los Angeles CA USA

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/petr.13042/fullpdf

Reference24 articles.

1. Pediatric kidney transplantation;Shapiro;Pediatr Clin North Am,2010

2. Rituximab and intravenous immune globulin for desensitization during renal transplantation;Vo;N Engl J Med,2008

3. Factors predicting risk for antibody-mediated rejection and graft loss in highly human leukocyte antigen sensitized patients transplanted after desensitization;Vo;Transplantation,2015

4. Desensitization in HLA-incompatible kidney recipients and survival;Montgomery;N Engl J Med,2011

5. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation;Vo;Transplantation,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of the sensitized pediatric renal transplant candidate;Pediatric Transplantation;2024-02-24

2. Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients;Clinical Transplantation;2022-06-12

3. Use of a donor‐derived cell‐free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection;Pediatric Transplantation;2022-03-27

4. Imlifidase Inhibits HLA Antibody-mediated NK Cell Activation and Antibody-dependent Cell-mediated Cytotoxicity (ADCC) In Vitro;Transplantation;2019-10-21